广东省紧密型医联体药事管理工作的调研分析  

Investigation and analysis of pharmaceutical management in compact medical consortium of Guangdong province

作　　者：朱晓丹 陈孝[2] 曹伟灵[3] 曾援 卢佐京 李学钧 陈文瑛 ZHU Xiaodan;CHEN Xiao;CAO Weiling;ZENG Yuan;LU Zuojing;LI Xuejun;CHEN Wenying(Dept.of Pharmacy,the Third Affiliated Hospital of Southern Medical University,Guangzhou 510630,China;Dept.of Pharmacy,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Shenzhen Luohu District People’s Hospital,Guangdong Shenzhen 518020,China;Dept.of Pharmacy,Nanxiong People’s Hospital,Guangdong Shaoguan 512400,China;Yangxi General Hospital,Guangdong Yangjiang 529800,China;Guangdong Provincial Health Commission,Guangzhou 510060,China)

机构地区：[1]南方医科大学第三附属医院药学部,广州510630 [2]中山大学附属第一医院药学部,广州510080 [3]深圳市罗湖区人民医院,广东深圳518020 [4]南雄市人民医院药学部,广东韶关512400 [5]阳西总医院,广东阳江529800 [6]广东省卫生健康委员会,广州510060

出　　处：《中国药房》2024年第4期390-394,共5页China Pharmacy

基　　金：中国药学会医院药学专业委员会医院药学科研专项(No.CPA-Z05-ZC-2021-002)。

摘　　要：目的调查广东省紧密型医联体的药事管理工作现状,为推动广东省医联体高质量建设和可持续发展提供决策依据。方法自行设计调查问卷,抽取广东省50家紧密型医联体为研究对象,由总院药学部负责人作答,调查内容包括医联体基本规模、医联体总药师聘任情况、医联体内药事管理与药学服务同质化执行情况、推动同质化的难点、希望获得的省级支持等,并对调查结果进行描述性统计分析。结果共回收问卷50份,有效回收率为100%。医联体总院药学部负责人有16人(占32.00%)被聘任为总药师。37家医联体(占74.00%)已建立医联体内药品供应保障体系,35家医联体(占70.00%)已开展医联体内药事管理统筹工作,23家医联体(占46.00%)已建立临床用药指导体系,25家医联体(占50.00%)已建立双向交流机制,仅8家医联体(占16.00%)有拓展药学服务新模式。目前推动医联体内药事管理与药学服务同质化的难点主要在于“各成员单位的管理水平差距较大”“药学人员缺乏、水平参差不齐”“政策支持与落实不足”3个方面。大部分医联体希望相关部门通过举办专项培训班或开展专项督导的方式推进药事工作向同质化发展。结论目前广东省紧密型医联体在落实总药师制度、药事管理与药学服务同质化建设方面取得了初步成效,但仍需提高医联体中总药师聘任的覆盖率,将药事管理同质化工作落实到位,并加快药学服务同质化进程。OBJECTIVE To investigate the current situation of pharmaceutical management in compact medical consortium of Guangdong province,and to provide decision-making basis for promoting the high-quality construction and sustainable development of the provincial medical consortium.METHODS A self-designed questionnaire was used to select 50 compact medical consortiums in Guangdong province.The survey was answered by the heads of the pharmacy department of the general hospitals.The survey covered the basic scale of the consortium,the appointment of chief pharmacists,the implementation of pharmaceutical management and pharmaceutical care homogenization within the consortium,the difficulties in promoting the homogenization,and the expected provincial support.Descriptive statistical analysis was performed on the survey results.RESULTS A total of 50 questionnaires were collected,and the effective recovery rate was 100%.There were 16 chief pharmacists(32.00%)in charge of the pharmacy department of the general hospital in the medical consortium.Thirty-seven medical consortiums(74.00%)had established a drug supply support system within the consortium,35 medical consortiums(70.00%)had carried out pharmaceutical management and coordination work within the medical consortium,23 medical consortiums(46.00%)had established a clinical medication guidance system,25 medical consortiums(50.00%)had established a bidirectional communication mechanism,and only 8 medical consortiums(16.00%)had developed new models of pharmaceutical care.At present,the difficulties in promoting the homogenization of pharmaceutical management and pharmaceutical care within the medical consortium were mainly found in three aspects:the wide gap in management level of each member unit,the lack and uneven level of pharmaceutical personnel,and insufficient policy support and implementation.Most medical consortiums hoped that relevant departments could promote the homogenization of pharmaceutical work by holding special training courses or special supervision.CONCLUSI

关 键 词：医联体 药事管理 药学服务 同质化 总药师制度 

分 类 号：R95[医药卫生—药学]